2139 views | 8 years ago
At Illumina we want our employees to connect with our mission and the communities where they live and work. To help make these connections, in June 2018, we partnered with the Jessie Rees Foundation...
717 views | 8 years ago
Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions...
3512 views | 8 years ago
We caught up with Anthony Philippakis, Chief Data Officer at The Broad Institute, and Susan Tousi, Senior Vice President of Product Development at Illumina, at the 2018 Bio-IT World Conference in Boston,...
10112 views | 8 years ago
It’s time to rethink NIPT. Introducing the VeriSeq NIPT solution, a powerful screening test from Illumina that can provide information on the health of a developing fetus using a simple maternal blood...
2540 views | 8 years ago
Dr. Martin Chavez, Chief of Maternal Fetal Medicine at Winthrop University Hospital discusses why he recommends noninvasive prenatal testing (NIPT). He notes that its accuracy, sensitivity, and specificity...
53316 views | 8 years ago
The VeriSeq™ NIPT solution from Illumina is a powerful screening test that provides the most comprehensive view of the fetal genome using a simple maternal blood draw. Cell-free DNA, released by placental...
6794 views | 8 years ago
The increased ease of next-generation sequencing (NGS) means more data to interpret than ever before. The process for variant annotation, curation, and interpretation can be extremely cumbersome. The...
2133 views | 8 years ago
Accelerate your research with the AmpliSeq for Illumina solution—the new workflow for your targeted next-generation sequencing (NGS) studies. Quickly identify, annotate, and classify disease-relevant...